| A Study to Assess the Potential CYP3A Induction Effect of Brensocatib on the Pharmacokinetics (PK) of Midazolam in Healthy Participants | Healthy Volunteers | Not yet recruiting | Phase 1 | 2026-10-05 | | NCT07859007 |
|---|
| Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-29 | | NCT07179380 |
|---|
| A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants | Healthy Volunteers | Recruiting | Phase 1 | 2026-09-25 | | NCT07765706 |
|---|
| A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-09-16 | | NCT07481981 |
|---|
| A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment | Hepatic Impairment | Recruiting | Phase 1 | 2026-09-11 | | NCT07643155 |
|---|
| A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF) | interstitial lung disease, lung disorder, respiratory system disorder | Not yet recruiting | Phase 3 | 2026-09-04 | | NCT07805785 |
|---|
| An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-08-20 | | NCT05649748 |
|---|
| An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-08-13 | | NCT07234032 |
|---|
| Development of a Canadian Bronchiectasis and NTM Database | bronchial disorder, bronchiectasis, respiratory system disorder | Recruiting | Not stated | 2023-11-22 | | NCT06144996 |
|---|